|
⚲
|
| Keyboard |
| Davis Hugh M
✚
|
|
|---|---|
| CIK # | 0002045027 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002045027] | |
| 4 | [0002045027] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Aclaris Therapeutics Inc | |
| Davis Hugh M |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Aclaris Therapeutics Inc ACRS
Common Stock
|
2026-02-03 | Option exercise | 18,675 | ||
|
Aclaris Therapeutics Inc ACRS
Restricted Stock Units · derivative
|
2026-02-03 | Option exercise | 18,675 | $0.00 | |
|
Aclaris Therapeutics Inc ACRS
Employee Stock Option (Right to Buy) · derivative
|
2026-02-02 | Grant | 336,300 | $0.00 | |
|
Aclaris Therapeutics Inc ACRS
Restricted Stock Units · derivative
|
2026-02-02 | Grant | 96,100 | $0.00 | |
|
Aclaris Therapeutics Inc ACRS
Restricted Stock Units · derivative
|
2025-12-02 | Option exercise | 26,750 | $0.00 | |
|
Aclaris Therapeutics Inc ACRS
Common Stock
|
2025-12-02 | Option exercise | 26,750 | ||
|
Aclaris Therapeutics Inc ACRS
Restricted Stock Units · derivative
|
2025-02-03 | Grant | 74,700 | $0.00 | |
|
Aclaris Therapeutics Inc ACRS
Employee Stock Option (Right to Buy) · derivative
|
2025-02-03 | Grant | 261,600 | $0.00 | |
|
Aclaris Therapeutics Inc ACRS
Restricted Stock Units · derivative
|
2024-12-02 | Grant | 107,000 | $0.00 | |
|
Aclaris Therapeutics Inc ACRS
Employee Stock Option (Right to Buy) · derivative
|
2024-12-02 | Grant | 375,000 | $0.00 |